Akirin2 is overexpressed in a number of tumor cell lines, and antisense-mediated knockdown of Akirin2 led to growth inhibition and reduced tumorigenicity and metastasis of K2 hepatoma and Lewis lung carcinoma cell lines [13, 18]. Here, AKIRIN2 is linked to hepatocellular carcinoma.